Russell Investments Group, Ltd. Ovid Therapeutics Inc. Transaction History

Russell Investments Group, Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$3.23 - $3.97 $184 - $226	57 New	57 $0
Q1 2023 May 09, 2023	SELL	$1.88 - $2.85 $2,361 - $3,579	-1,256 Reduced 0.47%	267,459 $690,000
Q3 2022 Nov 04, 2022	BUY	$1.85 - $2.26 $1,566 - $1,914	847 Added 0.32%	268,715 $492,000
Q2 2022 Jul 29, 2022	SELL	$1.69 - $3.31 $13,697 - $26,827	-8,105 Reduced 2.94%	267,868 $574,000
Q1 2022 May 05, 2022	SELL	$2.65 - $3.49 $81,044 - $106,734	-30,583 Reduced 9.98%	275,973 $865,000

Q4 2021 Jan 21, 2022	BUY	$3.13 - $3.73 $959,520 - $1.14 Million	306,556 New	306,556 $983,000
Q2 2021 Aug 04, 2021	SELL	$3.3 - $4.49 $344,133 - $468,230	-104,283 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$2.42 - $4.47 $252,364 - $466,145	104,283 New	104,283 $419,000
Q1 2019 May 13, 2019	SELL	$1.77 - $3.56 $885 - $1,780	-500 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$2.42 - $6.6 $1,210 - $3,300	500 New	500 $1,000

43.2M

5.9K

300

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $52.8M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.